Proliferative Diabetic Retinopathy (PDR)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Proliferative Diabetic Retinopathy (PDR) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingPhase 3

NCT06790784

Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR

This randomized trial will compare treatment strategies for proliferative diabetic retinopathy (PDR). Participants will receive either combination a of faricima…

United States426 participantsStarted 2025-08-04

Treatment: Vitrectomy, Endolaser

RecruitingEarly Phase 1

NCT06412224

The Preliminary Safety and Efficacy of RRG001 After Vitrectomy in Subjects With Proliferative Diabetic Retinopathy (PDR)

This study aims to slow down disease progression, reduce postoperative complications and decrease retreatment frequency in subjects with proliferative diabetic…

China6 participantsStarted 2023-12-20

Treatment: RRG001

All recent trials (59 shown)

Active — Not RecruitingPhase 4

NCT07118670

High Dose Eylea for Proliferative Diabetic Retinopathy Outcomes

The purpose of this Phase 4 study is to evaluate the safety of aflibercept 8mg in patients with proliferative diabetic retinopathy without center-involved diabe…

United States40 participantsStarted 2025-12-08

Treatment: Aflibercept 8mg

Not Yet RecruitingNot Applicable

NCT07315802

New Pattern of Retinal Laser Treatment for PDR

The objective of the study is to evaluate the efficacy of a new pattern of argon-laser in treating patients with proliferative diabetic retinopathy (PDR).

China300 participantsStarted 2026-01-01

Treatment: A new pattern of retinal laser

Proliferative Diabetic Retinopathy (PDR)

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR

The Preliminary Safety and Efficacy of RRG001 After Vitrectomy in Subjects With Proliferative Diabetic Retinopathy (PDR)

All recent trials (59 shown)

High Dose Eylea for Proliferative Diabetic Retinopathy Outcomes

New Pattern of Retinal Laser Treatment for PDR

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR

The Preliminary Safety and Efficacy of RRG001 After Vitrectomy in Subjects With Proliferative Diabetic Retinopathy (PDR)

All recent trials (59 shown)

High Dose Eylea for Proliferative Diabetic Retinopathy Outcomes

New Pattern of Retinal Laser Treatment for PDR

Fovea Sparing ILM Peeling in Diabetic Patients

Safety and Efficacy of Low-Fluence PRP for PDR

HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic E…

A Study on the Treatment Strategy of NVG Secondary to PDR

OCT and OCT-A Afer Diabetic Vitrectomy in PDR

Specular Microscopy in Patients With Proliferative Diabetic Retinopathy

Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy

Effect of Postvitrectomy Proactive Use of Conbercept on Postoperative Complications in PDR Patients

Establishment and Validation of a Risk Prediction Model for Long-term Low Vision After Vitrectomy in PDR Patients

The Effect of IVA for Preventing Postvitrectomy Hemorrhage in PDR

Ozurdex in Reducing PVR After Vitreotomy in PDR

Comparison of Surgery Outcome Between Preoperative IVR and Intraoperative IVR in PPV for PDR

Preoperative Bevacizumab and Ziv-Aflibercept Administration in PDR Subjects Undergoing PPV

ILM Peeling in PDR Patients Undergoing PPV for VH

Silicone Oil Versus Gas in PDR Patients Undergoing Vitrectomy

Anti-VEGF vs. Prompt Vitrectomy for VH From PDR

Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema

Intravitreal Bevacizumab vs Laser vs Combination of Bevacizumab and Modified Laser in PDR